Abstract 1193: Treatment of breast cancer xenografts with paclitaxel enriches for cancer stem cells that can be targeted by a ROR1-specific antibody

Although initially responsive to hormone therapy and chemotherapy, many patients with metastatic breast cancer develop resistant and potentially fatal disease. One of the mechanisms of resistance is the emergence of post-treatment survival of a small number of breast cancer stem cells (CSC), which a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer research (Chicago, Ill.) Ill.), 2016-07, Vol.76 (14_Supplement), p.1193-1193
Hauptverfasser:	Zhang, Suping, Liu, Grace, Lai, Sam H., Zhang, Han, Ghia, Emanuela M., Cui, Bing, Wu, Rongrong, Widhopf, George, Yu, Jian, Schwab, Richard, Messer, Karen, Parker, Barbara, Kipps, Thomas J.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!